Legal Representation
Attorney
David S. Harper
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 8, 2004 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Feb 14, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 26, 2002 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 28, 2002 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 5, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 13, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Aug 21, 2001 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 16, 2001 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Aug 15, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 10, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 042
Drug discovery product and diagnostic research services for others in the fields of cancer, autoimmune disorders, infectious disease, cardiovascular disorders, metabolic disorders and neurological disorders
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
PRIME CYTE
Classification
International Classes
042